Skip to main content
. Author manuscript; available in PMC: 2015 Aug 17.
Published in final edited form as: Ann Intern Med. 2015 Feb 17;162(4):266–275. doi: 10.7326/M14-1281

Appendix Table 2.

Medication Use, by Examination*

Medication Baseline
Ever Throughout Study
Men Women Men Women
Aspirin§ 546 (27.84) 484 (21.36) 1132 (57.73) 1214 (53.57)

Antihypertensive 642 (32.74) 821 (36.23) 1142 (58.24) 1362 (60.11)

Lipid-lowering|| 308 (15.71) 348 (15.36) 855 (43.60) 1009 (44.53)

Any 1031 (52.58) 1197 (52.82) 1563 (79.70) 1866 (82.35)

None 930 (47.42) 1069 (47.18) 398 (20.30) 400 (17.65)
*

Values are numbers (percentages).

Examination 1.

Observed medication use any time during the study but before an event when applicable. Includes participants with missing data on risk factors.

§

Regular use.

||

Lipid-lowering therapy included a statin in 92.5% of participants at baseline and 94.0% of participants ever throughout the study.

HHS Vulnerability Disclosure